i certainly would like to think that people can now start to realise how this company is now on its way to becoming a long term viable bona fide company, moving away from the ranks of speculative to growing into a revenue generating company. Yes there are those that didnt like the CR but at the end of the day it has strengthened the registry, strengthened the balance sheet and allows without any delays of funding which would have had to occur in 2018 to now accelerate (company words) the business model. With the money in the bank now it allows fast tracking opportunities as they may arise....this is purely speculation but who knows perhaps european and australian rollouts this year rather than staggered into Q1 2018.
DSA parternship is a real working relationship and they are the national government body for the dementia industry...who are giving the tick of approval for using the Epat app...
EPT Price at posting:
4.7¢ Sentiment: Buy Disclosure: Held
